News
We provide regular updates on our latest activities, research, and development.
Neu REFIX B-glucans improve Anti-aging Butyrate & gut microbiome
Neu REFIX B-glucans improve Anti-aging Butyrate & gut microbiome
Neu REFIX beta glucans improving Multiple Sclerosis patients’ gut microbiome awarded as the best poster in 6th Microbiome Asia Conference in Tokyo 26~27 April 2023
Neu REFIX beta glucans improving Multiple Sclerosis patients’ gut microbiome awarded as the best poster…
World Parkinson’s Day Webinar & Nichi BRITE Beta glucan clinical study report
Nichi BRITE Beta glucans yileding clinically encouraging outcome in a trial was presented in…
Neu-REFIX clinical and pre-clinical study results presented at MDA Muscular Dystrophy Conference 2023 in Neurology Live
Neurology Live, a clinical neurologists focused media portal has published GN Corporation’s presentation at the…
Neu REFIX Research on Duchenne Muscular Dystrophy to be presented at Muscular Dystrophy Association Conference 2023
GN Corporation will present the results of preclinical and clinical studies with neu REFIX (N-163),…
Commemoration of World Parkinson’s Day 2023
NICHI BRITE (AFO-202), one of the NICHI GLUCAN brand products for overseas markets, has undergone…
BEES-HAUS method yielding successful cell engraftment to prevent recurrence of urethral stricture confirmed; Manuscript published in Stem Cell Reviews and Reports
Manuscript published in Stem Cell Reviews and Reports
Autologous immune-cell therapy practiced in Japan, helping Vinmec Hospital after technology transfer
Technology transfer on cell therapy to Vietnam by GN Corporation leads to new opportunities
Webiner on “Cell Therapy Approaches for Urethral Stricture” jointly held with Edogawa Hospital
Webiner on Cell Therapy Approaches for Urethral Stricture is held on 16 OCt 2022